Skip to main content
Fig. 2 | Cancer Cell International

Fig. 2

From: Differential expression of VEGFR2 protein in HER2 positive primary human breast cancer: potential relevance to anti-angiogenic therapies

Fig. 2

ac CD34+ and VEGFR2+ vascular counts in various human breast cancer subtypes. Within each BRC subtype, cases were arranged from negative to low (1–5) to intermediate (6–10) to high (>10) VEGFR2+ vessel counts. As compared to hormone receptor positive (a) and triple negative (c) BRCs, a greater proportion of HER2+ (b) BRCs exhibited higher numbers of VEGFR2+ vessels in the tumor stroma (orange boxes)

Back to article page
\